Upregulation of DJ-1 expression in melanoma regulates PTEN/AKT pathway for cell survival and migration
- 21 September 2020
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 313 (7) , 583-591
Abstract
Cutaneous melanoma is known to be one of the most dangerous skin cancers because of its metastatic functions. Today, it is essential to investigate specific biomarkers for the target treatment in many diseases including cancers. DJ-1 protein, also known as Parkinson disease 7, has various functions associated with cancer progression including cell survival and migration. Phosphatase and tensin homolog (PTEN) is a tumor suppressor that regulates the PI3K/AKT signaling pathway and its mutations have been reported to frequently occur in many cancers such as thyroid, breast and skin. Recently, DJ-1 has been identified as a negative regulator of PTEN in many human cancer cells. However, the impacts and relationship of DJ-1 and PTEN have not been studied yet in melanoma. To confirm the expression of DJ-1 and PTEN in melanoma compared to normal skin tissues and find out functions of DJ-1 in melanoma cells, Western blot analysis and immunohistochemical staining were used. Transfection of G361 cells with DJ-1-specific small interfering RNA was performed to figure out the roles of DJ-1 and the relationship between DJ-1 and PTEN in melanoma cells. In our study, the DJ-1 protein was significantly increased with loss of PTEN protein in melanoma compared to that in normal skin. Inhibition of DJ-1 in G361 cells induced apoptosis, and suppressed cell survival and migration. Furthermore, suppression of DJ-1 in G361 cells increased the expression of cleaved caspase-3, cleaved PARP, Bax, p53, and Daxx as well as PTEN, while it decreased expression of survivin, caspase-3, and PARP. Also, downregulated DJ-1 inhibited phosphorylation of AKT in G361 cells. Collectively, DJ-1 overexpression could affect the proliferative and invasive capabilities of melanoma cells via regulating the PTEN/AKT pathway and apoptosis-related proteins. This study suggests that DJ-1 may be a potential target for the treatment of melanoma.Keywords
This publication has 28 references indexed in Scilit:
- Tumorigenesis role and clinical significance of DJ-1, a negative regulator of PTEN, in supraglottic squamous cell carcinomaJournal of Experimental & Clinical Cancer Research, 2012
- Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markersOncology Letters, 2011
- Serum DJ‐1 as a diagnostic marker and prognostic factor for pancreatic cancerJournal of Digestive Diseases, 2011
- DJ-1 Enhances Cell Survival through the Binding of Cezanne, a Negative Regulator of NF-κBJournal of Biological Chemistry, 2011
- Significance and relationship between DJ-1 gene and survivin gene expression in laryngeal carcinomaEuropean Journal of Histochemistry, 2011
- DJ‐1: A novel independent prognostic marker for survival in glottic squamous cell carcinomaCancer Science, 2010
- DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional ActivityJournal of Biological Chemistry, 2008
- Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinomaHuman Pathology, 2008
- PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanomaJournal of the American Academy of Dermatology, 2003
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997